Boston Therapeutics (QB) Stock Price - BTHE

0.0084
-0.0056 (-40.0%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Boston Therapeutics Inc (QB) BTHE OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0056 -40.0% 0.0084 0.0084 0.0084 0.0084 0.014 16:36:15
Bid Price Ask Price Spread Spread % News
0.005 0.075 0.07 93.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 1,123 $ 0.0084 $ 9 27,959 0.0052 - 0.035
Last Trade Time Type Quantity Stock Price Currency
10:45:18 40 $ 0.0109 USD

Boston Therapeutics (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 933.50k 111.13M $ -4.60M - - 43.38M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
23.11k $ - 0.00% - -

more financials information »

Boston Therapeutics (QB) News

Loading Messages....

Latest BTHE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTHE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.009740.0140.00840.01273372,256-0.00134-13.76%
1 Month0.015190.019990.007650.010704841,703-0.00679-44.7%
3 Months0.0240.0290.007650.017658932,387-0.0156-65.0%
6 Months0.01120.0290.00520.014163866,489-0.0028-25.0%
1 Year0.0320.0350.00520.016781567,807-0.0236-73.75%
3 Years0.0640.11640.00520.037152854,216-0.0556-86.88%
5 Years0.210.250.00520.056113348,942-0.2016-96.0%

Boston Therapeutics (QB) Description

Boston Therapeutics, Inc. (OTCQB: BTHE), headquartered in Lawrence, MA, is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: BTI-320, a non-systemic chewable compound designed to reduce post-meal glucose elevation; IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia; and SUGARDOWN(R), an OTC dietary supplement designed to lower post-meal sugar spike. More information on BTHE is available at www.bostonti.com.


Your Recent History
USOTC
BTHE
Boston The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.